Beneficial effects of the phytoestrogen genistein on hippocampal impairments of spontaneously hypertensive rats (SHR).

Hippocampal neuropathology is a recognized feature of the spontaneously hypertensive rat (SHR). The hippocampal alterations associate with cognitive impairment. We have shown that hippocampal abnormalities are reversed by 17ß-estradiol, a steroid binding to intracellular receptors (estrogen receptor α and ß subtypes) or the membrane-located G-protein coupled estradiol receptor. Genistein (GEN) is a neuroprotective phytoestrogen which binds to estrogen receptor ß and G-protein coupled estradiol receptor. Here, we investigated whether GEN neuroprotection extends to SHR. For this purpose, we treated 5-month-old SHR for 2 weeks with 10 mg kg-1 daily s.c injections of GEN. We analyzed the expression of doublecortin+ neuronal progenitors, glial fibrillary acidic protein+ astrocytes and ionized calcium-binding adapter molecule 1+ microglia in the CA1 region and dentate gyrus of the hippocampus using immunocytochemistry, whereas a quantitative real-time polymerase chain reaction was used to measure the expression of pro- and anti-inflammatory factors tumor necrosis factor α, cyclooxygenase-2 and transforming growth factor ß. We also evaluated hippocampal dependent memory using the novel object recognition test. The results showed a decreased number of doublecortin+ neural progenitors in the dentate gyrus of SHR that was reversed with GEN. The number of glial fibrillary acidic protein+ astrocytes in the dentate gyrus and CA1 was increased in SHR but significantly decreased by GEN treatment. Additionally, GEN shifted microglial morphology from the predominantly activated phenotype present in SHR, to the more surveillance phenotype found in normotensive rats. Furthermore, treatment with GEN decreased the mRNA of the pro-inflammatory factors tumor necrosis factor α and cyclooxygenase-2 and increased the mRNA of the anti-inflammatory factor transforming growth factor ß. Discrimination index in the novel object recognition test was decreased in SHR and treatment with GEN increased this parameter. Our results indicate important neuroprotective effects of GEN at the neurochemical and behavioral level in SHR. Our data open an interesting possibility for proposing this phytoestrogen as an alternative therapy in hypertensive encephalopathy.

Is the beta estradiol receptor receiving enough attention for its metabolic importance in postmenopause?

The relationship between menopause and the development of metabolic diseases is well established. In postmenopause women, there is an expansion of visceral white adipose tissue (WATv), which highly contributes to the rise of circulating lipids. Meanwhile, muscle glucose uptake decreases and hepatic glucose production increases. Consequently, in the pancreas, lipotoxicity and glycotoxicity lead to deficient insulin production. These factors initiate an energy imbalance and enhance the probability of developing cardiovascular and metabolic diseases. Although the activation of estradiol receptors (ER) has been shown to be beneficial for the WAT stock pattern, leading to the insulin-sensitive phenotype, authors have described the risk of these receptors' activation, contributing to neoplasia development. The selective activation of beta-type ER (ERß) seems to be a promising strategy in the treatment of energy imbalance, acting on several tissues of metabolic importance and allowing an intervention with less risk for the development of estrogen-dependent neoplasia. However, the literature on the risks and benefits of selective ERß activation still needs to increase. In this review, several aspects related to ERß were considered, such as its physiological role in tissues of energy importance, beneficial effects, and risks of its stimulation during menopause. PubMed, SciELO, Cochrane, and Medline/Bireme databases were used in this study.

Activation of the G Protein-Coupled Estrogen Receptor (GPER) Increases Neurogenesis and Ameliorates Neuroinflammation in the Hippocampus of Male Spontaneously Hypertensive Rats.

It is known that spontaneously hypertensive rats (SHR) present a marked encephalopathy, targeting vulnerable regions such as the hippocampus. Abnormalities of the hippocampus of SHR include decreased neurogenesis in the dentate gyrus (DG), partial loss of neurons in the hilus of the DG, micro and astrogliosis and inflammation. It is also known that 17ß-estradiol (E2) exert neuroprotective effects and prevent hippocampal abnormalities of SHR. The effects of E2 may involve a variety of mechanisms, including intracellular receptors of the ERα and ERß subtypes or membrane-located receptors, such as the G protein-coupled estradiol receptor (GPER). We have now investigated the protective role of GPER in SHR employing its synthetic agonist G1. To accomplish this objective, 5 month-old male SHR received 150 µg/day of G1 during 2 weeks. At the end of this period, we analyzed neuronal progenitors by staining for doublecortin (DCX), and counted the number of glial fibrillary acidic protein (GFAP)-labeled astrocytes and Iba1-stained microglial cells by computerized image analysis. We found that G1 activation of GPER increased DCX+ cells in the DG and reduced GFAP+ astrogliosis and Iba1+ microgliosis in the CA1 region of hippocampus. We also found that the high expression of proinflammatory makers IL1ß and cyclooxygenase 2 (COX2) of SHR was decreased after G1 treatment, which correlated with a change of microglia phenotype from the activated to a resting morphology. Additionally, G1 treatment increased the anti-inflammatory factor TGFß in SHR hippocampus. Altogether, our results suggest that activation of GPER plays a neuroprotective role on the encephalopathy of SHR, an outcome resembling E2 effects but avoiding secondary effects of the natural hormone.

Avaliação dos efeitos do Bisfenol A em queratinócitos e células de neoplasia de cavidade oral / Evaluation of bisphenol A effects in keratinocytes and oral cavity neoplasia cells

O Bisfenol A (BPA) é um monômero utilizado na produção de garrafas plásticas, embalagens alimentícias, resinas odontológicas e vários outros materiais. Este monômero age como um desregulador do sistema endócrino e seus efeitos estão associados a cânceres em diferentes órgão e tecidos, como mama, próstata e tireóide. O BPA já foi detectado em fluidos humanos, incluindo saliva, mas os seus efeitos na mucosa bucal e em células orais neoplásicas não foram investigados. Os objetivos do presente trabalho foram 1) verificar os efeitos da exposição crônica ao BPA em glândulas salivares e mucosa bucal in vivo e 2) avaliar os efeitos do BPA in vitro em células de neoplasias bucais e queratinócitos; Para atender ao objetivo 1, camundongos machos e fêmeas receberam BPA (200 mg/mL) na água de beber durante 6 semanas. As mucosas orais (palato, língua e mucosa jugal) e as glândulas submandibulares foram avaliadas. Para atender ao objetivo 2, a resposta ao BPA foi examinada nas linhagens NOK-SI (queratinócito), HN12, HN13 (CCE de cavidade oral), UM HMC1 e UM HMC3a (neoplasia de glândula salivar). Os seguintes parâmetros foram avaliados: viabilidade, proliferação, invasão, angiogênese, produção de citocinas e fatores de crescimento e possíveis mecanismos de ação do BPA. Resultados. A exposição de camundongos ao BPA resultou em alterações microscópicas caracterizadas pelo aumento da espessura do epitélio da mucosa oral (palato, língua e mucosa jugal) e uma redução no número de ácinos das glândulas submandibulares. Foi observado também um acúmulo de BPA nos tecidos orais. In vitro, nas linhagens de CCE, o BPA aumentou a proliferação, invasão celular e os níveis da proteína vimentina, e ainda induziu a secreção de citocinas e fatores de crescimento, e a acetilação de histonas H3. Em queratinócitos orais, o BPA aumentou a proliferação celular e induziu a secreção de fatores de crescimento e a expressão de receptores de estrógeno (ER) α e ß. Os efeitos do BPA foram revertidos na presença do antagonista puro do ER. Nas linhagens de neoplasias de glândula o BPA não alterou a proliferação e induziu a expressão de p63. Em conclusão, o BPA induz alterações morfológicas nos tecidos bucais e alterações moleculares nos queratinócitos e nas células de CCE de cavidade oral. Os mecanismos pelos quais o BPA induz estas alterações são dependentes da interação BPA-ER e da acetilação de histonas.

Bisphenol A (BPA) is a monomer used to product plastic bottles, food packaging, inner coating of food cans, thermal papers, medical devices, dental resins and various other materials. Due to its chemical structure, this monomer acts as a deregulator of the endocrine system and its effects are associated with cancers in different organs and tissues such as breast, endometrium, ovary, prostate, testis and thyroid. BPA has been detected in several human fluids, including saliva, however its effects on the normal oral mucosa and neoplastic oral cells have not been investigated yet. Thus, the objectives of the present study were 1) to verify the effects of chronic exposure to BPA in salivary glands and oral mucosa in vivo and 2) to evaluate the effects of BPA in vitro on oral tumor cells and keratinocytes. To meet objective 1, male and female mice received BPA (200 mg / mL) in drinking water for 6 weeks. The oral mucosa (palate, tongue and buccal mucosa) and submandibular salivary glands were evaluated microscopically. To meet objective 2, the response to BPA was examined in immortalized cell lines NOK SI (keratinocyte); HN12, HN13 (OSCC), UM HMC1 and UM HMC3a (salivary gland tumor). The following parameters were evaluated: viability, proliferation, invasion, angiogenesis, cytokine and growth factors production. Results. Exposure of mice to BPA resulted in microscopic changes characterized by increased thickness of the oral mucosa epithelium (palate, tongue and buccal mucosa) and a reduction in the number of submandibular salivary glands acini. There was also an accumulation of BPA in the oral tissues. In vitro, in OSCC cells, BPA increased cell proliferation and invasion, vimentin expression, induced secretion of cytokines and growth factors, and induced histone H3 acetylation. In oral keratinocytes, BPA increased cell proliferation and induced secretion of growth factors and estrogen receptor (ER) α and ß expression. The effects of BPA were reversed in the presence of the pure ER antagonist. In salivary gland tumor cell lines, BPA did not alter the proliferation and induced the expression of p63. BPA mechanism of action involves its interaction with ER, since the effects were reverted in the presence of pure receptor antagonist. In conclusion, BPA induces morphological changes in oral tissues and molecular changes in keratinocytes and OSCC cells. The mechanisms which BPA induces these changes are dependent to the BPA-ER interaction and histone acetylation.

The molecular nature of the 17ß-Estradiol binding site in the voltage- and Ca2+-activated K+ (BK) channel ß1 subunit.

The accessory ß1 subunit modulates the Ca2+- and voltage-activated K+ (BK) channel gating properties mainly by increasing its apparent Ca2+ sensitivity. ß1 plays an important role in the modulation of arterial tone and blood pressure by vascular smooth muscle cells (SMCs). 17ß-estradiol (E2) increases the BK channel open probability (Po) in SMCs, through a ß1 subunit-dependent modulatory effect. Here, using molecular modeling, bioinformatics, mutagenesis, and electrophysiology, we identify a cluster of hydrophobic residues in the second transmembrane domain of the ß1 subunit, including the residues W163 and F166, as the binding site for E2. We further show that the increase in Po induced by E2 is associated with a stabilization of the voltage sensor in its active configuration and an increase in the coupling between the voltage sensor activation and pore opening. Since ß1 is a key molecular player in vasoregulation, the findings reported here are of importance in the design of novel drugs able to modulate BK channels.

Effect of estrogen administration on middle cerebral arterial viscoelastic properties in aged female rats.

PURPOSE:: To develop a model for studying cerebrovascular disease prevention in elderly women. METHODS:: Sixty 18-month-old Sprague Dawley (SD) rats were randomly divided into an estrogen administration group (EA, n=30) and a non-administration group (NA, n=30); thirty 4-month-old SD rats were allocated to a control group. The EA group received estradiol benzoate starting on the 5th day of a 34-day breeding period, and the serum levels of estradiol (E2), estrogen receptor (ER), and malondialdehyde (MDA) were measured. The MCA of each group was then sampled for viscoelastic experiments. RESULTS:: The serum levels of E2 and MDA in the EA group showed significant differences compared to those in the control group (p<0.05), while the difference in ER between the EA and control groups was not significant (p>0.05). The decrease in MCA stress at 7,200 s and the increase in strain at 7,200 s in the EA group showed no significant differences compared to the control group (p>0.05). CONCLUSION:: Estradiol administration inhibited the formation of lipid peroxidation products and restored middle cerebral arterial viscoelasticity in aged female rats.

Effect of estrogen administration on middle cerebral arterial viscoelastic properties in aged female rats

ABSTRACT PURPOSE: To develop a model for studying cerebrovascular disease prevention in elderly women. METHODS: Sixty 18-month-old Sprague Dawley (SD) rats were randomly divided into an estrogen administration group (EA, n=30) and a non-administration group (NA, n=30); thirty 4-month-old SD rats were allocated to a control group. The EA group received estradiol benzoate starting on the 5th day of a 34-day breeding period, and the serum levels of estradiol (E2), estrogen receptor (ER), and malondialdehyde (MDA) were measured. The MCA of each group was then sampled for viscoelastic experiments. RESULTS: The serum levels of E2 and MDA in the EA group showed significant differences compared to those in the control group (p<0.05), while the difference in ER between the EA and control groups was not significant (p>0.05). The decrease in MCA stress at 7,200 s and the increase in strain at 7,200 s in the EA group showed no significant differences compared to the control group (p>0.05). CONCLUSION: Estradiol administration inhibited the formation of lipid peroxidation products and restored middle cerebral arterial viscoelasticity in aged female rats.

Apoptosis, proliferation and presence of estradiol receptors in the testes and Bidder's organ of the toad Rhinella arenarum (Amphibia, Anura).

The dynamic equilibrium between spermatogonial proliferation and testicular apoptosis determines the progression of spermatogenesis in amphibians. Estrogens and their receptors play a central role in regulating spermatogenesis in vertebrates, and in some species of anurans, estradiol (E2 ) is involved in the regulation of spermatogonial proliferation and apoptosis of germ cells. Bidder's organ (BO) is a structure characteristic of Bufonidae that has historically been compared to an undeveloped ovary. In adult Rhinella arenarum males, BO is one of the main sources of plasma E2 . The aim of this study was 1) to describe the seasonal variations in testicular apoptosis, spermatogonial proliferation, and cellular proliferation in BO; and 2) to analyze the presence and localization of estrogen receptor ß (ERß) in the testes and BO of R. arenarum. Testicular fragments and BOs from animals collected during the year were labeled with 5-bromo-2'-deoxyuridine (BrdU) and BrdU incorporation was determined using immunohistochemistry. Apoptosis in testicular sections was detected using the TUNEL method, and ERß localization was assessed using immunohistochemistry in testes and BOs. The results indicate that spermatogonial proliferation is highest during the reproductive season and that cysts of spermatocytes and spermatids undergo apoptosis during the postreproductive season. Furthermore, the proliferation of follicular cells is highest during the reproductive and postreproductive seasons. ERß was primarily detected by immunolocalization in Sertoli cells, follicular cells, and oocytes. Taken together, these results suggest that cysts that do not form spermatozoa are removed from testes by apoptosis and that estrogens regulate both spermatogenesis and oogenesis in adult males of R. arenarum.

Expressão endometrial de receptores de estradiol e progesterona em éguas cíclicas, gestantes e acíclicas tratadas com hormônios esteroidais / Endometrial expression of estradiol and progesterone receptors in cyclic, pregnant and non-cyclic steroid treated mares

A utilização de éguas receptoras cíclicas e acíclicas nos programas de transferência de embriões (TE) é uma prática consagrada na reprodução equina. Uma alternativa vantajosa para criadores e veterinários é o uso das receptoras acíclicas, uma vez que viabiliza a antecipação da estação de monta e reduz o manejo com as receptoras. Para se estabelecer a gestação nestas receptoras, estrógenos e progestinas são administrados, de forma a simular o ambiente hormonal uterino de éguas que se tornam naturalmente gestantes. A administração de estrógenos previamente às progestinas é baseada nos estudos em éguas cíclicas, que mostram que o estradiol, presente no período de estro, estimula a expressão dos seus próprios receptores e dos receptores para progesterona no endométrio. A progesterona, por sua vez, provoca mudanças uterinas que possibilitam o estabelecimento e manutenção da gestação e leva a redução dos receptores de estradiol e de seus próprios receptores durante o diestro e início da gestação. No entanto, pouco se sabe sobre os receptores endometriais de estradiol e progesterona em éguas acíclicas, principalmente utilizadas em programas de TE. O presente trabalho revisa o padrão de expressão gênica dos receptores endometriais de estradiol e progesterona em éguas durante o ciclo estral, início da gestação e submetidas a tratamentos hormonais com estrógenos e progestinas exógenas. (AU)

The use of cyclic and non cyclic recipient mares in embryo transfer (ET) programs is a well established practice in equine reproduction. An advantageous alternative for horse owners and veterinarians is the use of non-cyclic recipients, since it makes possible the anticipation of the breeding season and reduces handling with the recipients. In order to establish pregnancy in the non-cyclic recipients, estrogens and progestins are administered to allow the induction of similar endometrial changes to those which occur in naturally pregnant mares. Administration of estradiol prior to progestins is based on cyclic mares researches, where estradiol produced during estrous stimulates the expression of estrogen and progesterone receptors in the endometrium. On the other hand, progesterone causes uterine changes that allow pregnancy establishment and maintenance. In addition, progesterone leads to reduction of estrogen and progesterone receptors during diestrous in cyclic mares. However, little is known about estrogen and progesterone endometrial receptors in non-cyclic mares, especially used in ET programs. The current study revises the gene expression pattern of estradiol and progesterone endometrial receptors in mares during estrous cycle, early pregnancy and submitted to estrogens and progestins hormonal treatments. (AU)

Expressão endometrial de receptores de estradiol e progesterona em éguas cíclicas, gestantes e acíclicas tratadas com hormônios esteroidais / Endometrial expression of estradiol and progesterone receptors in cyclic, pregnant and non-cyclic steroid treated mares

A utilização de éguas receptoras cíclicas e acíclicas nos programas de transferência de embriões (TE) é uma prática consagrada na reprodução equina. Uma alternativa vantajosa para criadores e veterinários é o uso das receptoras acíclicas, uma vez que viabiliza a antecipação da estação de monta e reduz o manejo com as receptoras. Para se estabelecer a gestação nestas receptoras, estrógenos e progestinas são administrados, de forma a simular o ambiente hormonal uterino de éguas que se tornam naturalmente gestantes. A administração de estrógenos previamente às progestinas é baseada nos estudos em éguas cíclicas, que mostram que o estradiol, presente no período de estro, estimula a expressão dos seus próprios receptores e dos receptores para progesterona no endométrio. A progesterona, por sua vez, provoca mudanças uterinas que possibilitam o estabelecimento e manutenção da gestação e leva a redução dos receptores de estradiol e de seus próprios receptores durante o diestro e início da gestação. No entanto, pouco se sabe sobre os receptores endometriais de estradiol e progesterona em éguas acíclicas, principalmente utilizadas em programas de TE. O presente trabalho revisa o padrão de expressão gênica dos receptores endometriais de estradiol e progesterona em éguas durante o ciclo estral, início da gestação e submetidas a tratamentos hormonais com estrógenos e progestinas exógenas.

The use of cyclic and non cyclic recipient mares in embryo transfer (ET) programs is a well established practice in equine reproduction. An advantageous alternative for horse owners and veterinarians is the use of non-cyclic recipients, since it makes possible the anticipation of the breeding season and reduces handling with the recipients. In order to establish pregnancy in the non-cyclic recipients, estrogens and progestins are administered to allow the induction of similar endometrial changes to those which occur in naturally pregnant mares. Administration of estradiol prior to progestins is based on cyclic mares’ researches, where estradiol produced during estrous stimulates the expression of estrogen and progesterone receptors in the endometrium. On the other hand, progesterone causes uterine changes that allow pregnancy establishment and maintenance. In addition, progesterone leads to reduction of estrogen and progesterone receptors during diestrous in cyclic mares. However, little is known about estrogen and progesterone endometrial receptors in non-cyclic mares, especially used in ET programs. The current study revises the gene expression pattern of estradiol and progesterone endometrial receptors in mares during estrous cycle, early pregnancy and submitted to estrogens and progestins hormonal treatments.

Sexual hormones: effects on cardiac and mitochondrial activity after ischemia-reperfusion in adult rats. Gender difference.

In this work we studied the influence of sex hormones on heart and mitochondrial functions, from adult castrated female and male, and intact rats. Castration was performed at their third week of life and on the fourth month animals were subjected to heart ischemia and reperfusion. Electrocardiogram and blood pressure recordings were made, cytokines levels were measured, histopathological studies were performed and thiobarbituric acid reactive species were determined. At the mitochondrial level respiratory control, transmembranal potential and calcium management were determined; Western blot of some mitochondrial components was also performed. Alterations in cardiac function were worst in intact males and castrated females as compared with those found in intact females and castrated males, cytokine levels were modulated also by hormonal status. Regarding mitochondria, in those obtained from hearts from castrated females without ischemia-reperfusion, all evaluated parameters were similar to those observed in mitochondria after ischemia-reperfusion. The results show hormonal influences on the heart at functional and mitochondrial levels.

Progesterone and estradiol effects on SRC-1 and SRC-3 expression in human astrocytoma cell lines.

Progesterone (P(4)) and estradiol (E(2)) regulate many cell functions through their interaction with specific intracellular receptors, which require the participation of coactivators such as SRC-1 and SRC-3 for enhancing their transcriptional activity. Coactivator expression is altered in many cancers and in some of them their expression is regulated by P(4) and E(2). In this study, we determined progesterone and estrogen receptor isoform expression in two human astrocytoma cell lines with different evolution grade (U373, grade III; and D54, grade IV) by Western Blot. We studied the role of P(4) and E(2) on SRC-1 and SRC-3 expression in U373 and D54 cell lines by RT-PCR and Western blot. In U373 cells, P(4) did not modify SRC-1 expression, but in D54 cells it increased SRC-1 mRNA expression after 12 h of treatment without significant changes after 24 h. P(4) also increased SRC-1 protein content after 24 h, but reduced it after 48 h. E(2) did not change SRC-1 expression in any cell line. SRC-3 expression was not regulated by either E(2) or P(4). Our data suggest that SRC-1 and SRC-3 expression is differentially regulated by sex steroid hormones in astrocytomas and that P(4) regulates SRC-1 expression depending on the evolution grade of human astrocytoma cells.

Biotin deficiency and biotin excess: effects on the female reproductive system.

Biotin deficiency and biotin excess have both been found to affect reproduction and cause teratogenic effects. In the reproductive tract, however, the effects of biotin have not been well established yet. We investigated the effects of varying biotin content diets on the oestrus cycle, ovarian morphology, estradiol and progesterone serum levels, and the uterine mRNA abundance of their nuclear receptors, as well as on the activity of the estradiol-degrading group of enzymes cytochrome P450 (CYP) in the liver. Three-week-old female BALB/cAnN Hsd mice were fed a biotin-deficient, a biotin-control, or a biotin-supplemented diet (0, 7.2 or 400 micromol of free biotin/kg diet, respectively) over a period of nine weeks. Striking effects were observed in the biotin-deficient group: mice showed arrested estrous cycle on the day of diestrus and changes in ovary morphology. Estradiol serum concentration increased 49.2% in biotin-deficient mice compared to the control group, while the enzymatic activities of CYP1A2 and CYP2B2 increased (P<0.05). The mRNA abundance of nuclear estrogen and progesterone receptors decreased in the biotin-deficient mice. In the biotin-supplemented group we found that, in spite of a significant (P<0.05) decrease in the number of primary and Graafian follicles and in CYP1A2 activities, mice exhibited 105.4% higher serum estradiol concentration than the control group. No changes in the expression of the nuclear receptors were observed. No significant differences were observed in serum progesterone among the groups. Our results indicate that both the deficiency and the excess of biotin have significant effects on the female mouse reproductive system.

The role of progesterone in endometrial estradiol- and progesterone-receptor synthesis in women with menstrual disorders and habitual abortion.

The objective of this comparative study was to determine the influence of changes in estradiol and progesterone during ovulatory vs. anovulatory cycles on levels of estradiol receptor (ER) and progesterone receptor (PgR) in endometrium. Thirty women (range age 20-35 years) were divided into three groups: women with a history of habitual abortion, obese women with menstrual disorders, and women with regular ovulatory cycles as well as proven fertility. A single venous blood sample and an endometrial sample were simultaneously obtained during the secretory phase of the menstrual cycle, in order to measure estradiol and progesterone levels and ER and PgR concentrations in cytosol and salt-extracted nucleosol. Plasma estradiol levels were not different between groups. Plasma progesterone was two times higher in fertile women than in habitual aborters. In endometrial tissue, progesterone content was 200 times higher in fertile women than in habitual aborters. ER and PgR were lower in the cytosol than in the nuclear fraction in fertile and obese women. Both receptors were at their lowest level in the cytosol and nuclear compartment of women with recurrent miscarriage. Fluctuations mainly in the sex hormone progesterone, in plasma and endometrium tissue, could interfere with ER and PgR levels.

17-beta-Estradiol upregulates COX-2 in the rat oviduct.

We investigated the regulation of cyclooxygenase-2 (COX-2) by 17-beta-estradiol (E2) in the rat oviduct. We observed that COX-2 is expressed mainly in proestrous and estrous stages, periods under estrogenic influence. While exogenous administration of E2 (1 microg/rat) significantly increased COX-2 protein levels, progesterone did not modify it. COX-2 was mainly localized on oviductal epithelial cells from estrogenized rat. Induction of COX-2 expression by E2 was partially reverted by tamoxifen (1 mg/rat), an E2 receptor antagonist. Estradiol treatment also increased prostaglandins (PGs) synthesis: 6-keto-PGF(1alpha) (40%), a stable metabolite of prostacyclin (PGI2), PGF(2alpha) (40%) and PGE2 (50%). Tamoxifen completely suppressed this enhancement. In order to discriminate which isoform of COX was implicated in the stimulatory effect of E2 on PGs synthesis, oviducts were preincubated with meloxicam (Melo: 10(-9)M) or NS-398 (10(-7)M), two selective COX-2 inhibitors. Both Melo and NS-398 abolished the increase of PGs synthesis stimulated by E2. All together, these data indicate that E2 could upregulate COX-2 expression and activity in the rat oviduct and that the stimulatory effect of E2 may be receptor-mediated.

Changes in alpha-estradiol receptor and progesterone receptor expression in the locus coeruleus and preoptic area throughout the rat estrous cycle.

We have previously shown that the locus coeruleus (LC) is essential for triggering surges of LH. Since LC neurons are responsive to estradiol, which induces progesterone receptor (PR) expression, this study aimed to investigate whether LC neurons express the alpha-estradiol receptor (alphaER) and PR as well as comparing such responses to that observed in the preoptic area (POA). Female rats were perfused at 10, 14 and 16 h on each day of the estrous cycle, and a blood sample was collected for estradiol, progesterone and LH measurements. alphaER- and PR immunoreactive (ir) neurons were detected in POA and LC by immunocytochemistry (ICC). Higher plasma estradiol levels were observed on the day of proestrus, when a smaller number of alphaER-ir POA neurons were detected. An increase in the number of alphaER-ir neurons were observed at 16 h of proestrus and estrus. The number of PR-ir neurons increased in POA only at 16 h of proestrus, and remained unchanged during all other days and times. The profile of alphaER-ir and PR-ir neurons in LC changed over the estrous cycle, with a lower expression on metestrus morning and reaching a peak on diestrus afternoon before declining on the day of proestrus. However, on estrus afternoon, alphaER-ir neurons increased, while PR-ir neurons decreased which may be related to the prolactin surge of estrus. These data show that LC neurons express alphaER and PR and seem to be more sensitive to variations in estradiol than POA. Also, the fluctuation in alphaER and PR observed for LC neurons seems to accompany the hormonal events that occur during the estrous cycle. This profile of alphaER and PR expression might be related to the ability of estradiol and progesterone in regulating the activity of LC neurons, which could be associated to the control mechanisms of LH and prolactin release.

Prostatic cancer/benign prostatic hypertrophy. Subcellular distribution of estradiol/androgen receptors.

Six microsomal population of estradiol and androgen receptors have been characterized in human benign prostatic hypertrophy (BPH) and prostate cancer (PCa). Estradiol receptor (ER) and androgen receptors (AR) were extracted using 0.6 M KCL and determined by the dextran-coated charcoal method. ER and AR levels were smaller in BPH plasma membranes (PM) than in Pca cases. For functions 3, 4, 6, the ER values in PCa were 25-38% less with regard to BPH ER values. Whereas in PCa, AR values obtained in all fractions were higher when compared to BPH AR values. In benign prostatic hypertrophy and prostatic cancer, ER and AR levels were significantly higher in the nuclear fraction. In the nuclear fraction, ER and AR levels in BPH and PCa were significantly different. The subcellular distribution of AR and ER in BPH and PCa constitutes a reservation mechanism and processing a receptors for their continued growth.

Estradiol regulates the slow Ca2+-activated K+ current in hippocampal pyramidal neurons.

The slow Ca2+-activated K+ current (sIAHP) was recorded in CA1 pyramidal neurons in hippocampal slices obtained from ovariectomized (OVX) or sham OVX (control) female rats. The sIAHP was significantly larger in cells from OVX rats than in cells from control rats. Superfusion with 5-100 nm 17beta-estradiol (E2) caused a progressive decrease in the sIAHP in cells from OVX rats but not in cells from control rats. In slices from OVX rats injected with 10 microg of E2 24 and 48 hr before they were killed, superfusion with E2 did not modify the sIAHP. In neurons from OVX rats, but not in neurons from control rats, E2 significantly increased both the number of action potentials and the burst duration generated by depolarizing pulses. The inactive isomer 17alpha-estradiol had no effect. The impermeant protein conjugate E2--BSA was as effective as free E2 at decreasing the sIAHP. Ca2+ spikes were also depressed by E2 in neurons from OVX rats, but not in control rats. A decrease in the intracellular Ca2+ signal, correlating with the inhibition of the Ca2+ spike and sIAHP produced by E2, was observed only in neurons from OVX rats. Our results indicate that ovariectomy increases the sIAHP and depresses excitability, whereas bath application or priming with E2 decreases the sIAHP, thus promoting excitability. These effects of E2 on the sIAHP and excitability, which are stereospecific and presumably mediated by membrane-bound receptors, could contribute to the hormonal regulation of synaptic plasticity and epileptiform activity as well as to learning and cognitive abilities dependent on the function of hippocampal neural circuits.

Estradiol receptor binding to the epithelium of uterine lumen and glands: region- and time-related changes during preimplantation and periimplantation periods studied by autoradiography.

The presence and changes of estradiol nuclear binding and related functions in uterine luminal and glandular epithelium were studied before and after blastocyst implantation using receptor autoradiography with (3)H-estradiol-17beta in association with (3)H-thymidine incorporation and immunocytochemical binding of antibody to estrogen receptor ER-alpha. (3)H-estradiol nuclear binding is present but variable during days 1.5-7.5 of pregnancy. Sites of strong nuclear binding of (3)H-estradiol exhibit strong immunocytochemical staining with ER-alpha antibody. Qualitative and quantitative evaluation of autoradiograms reveal that there is a general increase of nuclear (3)H-estradiol binding during the first 3 days after fertilization in both luminal and glandular epithelium. The binding of estradiol is stronger in glandular epithelium from day 2.5 to day 7.5, paralleled by a rise in (3)H-thymidine incorporation on day 2.5. By comparison, in the epithelium of the uterine lumen (3)H-estradiol nuclear binding is low, but relatively high in epithelial cells at lateral branching of the lumen where the increase in (3)H-estradiol binding corresponds to an increased labeling index with (3)H-thymidine. A highly differentiated binding of (3)H-estradiol to luminal and glandular epithelium was demonstrated with region- and time-specific changes of related effects on cell proliferation, differentiation, and secretion, probably involving involution and remodeling. The strong (3)H-estradiol binding to glandular epithelium suggests that estradiol exerts pronounced effects on glandular activities in the periimplantation period.

Role of estradiol-17beta on nuclear and cytoplasmic maturation of pig oocytes.

The role of estradiol-17beta on nuclear and cytoplasmic maturation of pig oocytes was investigated in the present study. To determine the estradiol effect, oocytes were cultured for 42 h in a steroid free medium composed of mTCM-199 supplemented with LH, FSH and 10% charcoal extracted follicular fluid. Estradiol receptor (ER), detected by a binding assay, were present in cumulus cells and oocytes during maturation with higher levels observed at 24 h of culture in the oocytes and at 36 h in the cumulus cells. To block estradiol action an antiestrogen (1-p-dimethylaminoethoxyphenyl-1,2-diphenyl-1-butene (tamoxifen)) was added to the maturation medium at various concentrations. The percentage of treated oocytes that underwent nuclear maturation was similar (P>0.05) to the control group. Cytoplasmic maturation, determined by the ability to form female pronucleus (FPN) and male pronucleus (MPN), was not different (P>0.05) among all groups. The presence of 4-hydroxy-4-androstene-3-17-dione (4-OHA) also did not influence nuclear (P>0.05) or cytoplasmic maturation (P>0.05). The results suggest that estradiol is not involved in maturation of pig oocytes. However, the present experiment used pronuclei formation as the endpoint, no studies were done in regard to estradiol's effects on the embryonic development.